ISE Chemicals Corporation (TYO:4107)
Japan
· Delayed Price · Currency is JPY 24,980
-190 (-0.75%)
Feb 21, 2025, 3:30 PM JST
ISE Chemicals Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 33,287 | 26,413 | 25,564 | 20,354 | 16,859 | Upgrade
|
| Revenue Growth (YoY) | 26.03% | 3.32% | 25.60% | 20.73% | 0.03% | Upgrade
|
| Cost of Revenue | 23,178 | 19,027 | 19,892 | 15,906 | 13,073 | Upgrade
|
| Gross Profit | 10,109 | 7,386 | 5,672 | 4,448 | 3,786 | Upgrade
|
| Selling, General & Admin | 2,450 | 1,789 | 1,624 | 1,443 | 1,320 | Upgrade
|
| Research & Development | - | 260 | 260 | 264 | 248 | Upgrade
|
| Operating Expenses | 2,450 | 2,089 | 1,915 | 1,738 | 1,600 | Upgrade
|
| Operating Income | 7,659 | 5,297 | 3,757 | 2,710 | 2,186 | Upgrade
|
| Interest Expense | -2 | -1 | -1 | -1 | -1 | Upgrade
|
| Interest & Investment Income | 12 | 5 | 3 | 6 | 10 | Upgrade
|
| Currency Exchange Gain (Loss) | -233 | -185 | -103 | -25 | -58 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -3 | -1 | Upgrade
|
| EBT Excluding Unusual Items | 7,436 | 5,116 | 3,656 | 2,687 | 2,136 | Upgrade
|
| Gain (Loss) on Sale of Assets | 2 | 4 | 3 | - | - | Upgrade
|
| Asset Writedown | -29 | -101 | -76 | -96 | -78 | Upgrade
|
| Other Unusual Items | 1 | 180 | 15 | - | -70 | Upgrade
|
| Pretax Income | 7,410 | 5,199 | 3,598 | 2,591 | 1,988 | Upgrade
|
| Income Tax Expense | 2,339 | 1,527 | 1,036 | 818 | 645 | Upgrade
|
| Net Income | 5,071 | 3,672 | 2,562 | 1,773 | 1,343 | Upgrade
|
| Net Income to Common | 5,071 | 3,672 | 2,562 | 1,773 | 1,343 | Upgrade
|
| Net Income Growth | 38.10% | 43.33% | 44.50% | 32.02% | 12.76% | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | -0.01% | -0.02% | - | -0.02% | - | Upgrade
|
| EPS (Basic) | 995.01 | 720.42 | 502.55 | 347.78 | 263.38 | Upgrade
|
| EPS (Diluted) | 995.01 | 720.42 | 502.55 | 347.78 | 263.38 | Upgrade
|
| EPS Growth | 38.11% | 43.35% | 44.50% | 32.04% | 12.76% | Upgrade
|
| Free Cash Flow | 689 | 2,490 | 75 | 5 | -201 | Upgrade
|
| Free Cash Flow Per Share | 135.19 | 488.52 | 14.71 | 0.98 | -39.42 | Upgrade
|
| Dividend Per Share | 360.000 | 270.000 | - | 120.000 | 90.000 | Upgrade
|
| Dividend Growth | 33.33% | - | - | 33.33% | 20.00% | Upgrade
|
| Gross Margin | 30.37% | 27.96% | 22.19% | 21.85% | 22.46% | Upgrade
|
| Operating Margin | 23.01% | 20.05% | 14.70% | 13.31% | 12.97% | Upgrade
|
| Profit Margin | 15.23% | 13.90% | 10.02% | 8.71% | 7.97% | Upgrade
|
| Free Cash Flow Margin | 2.07% | 9.43% | 0.29% | 0.02% | -1.19% | Upgrade
|
| EBITDA | 9,634 | 7,267 | 5,569 | 4,199 | 3,497 | Upgrade
|
| EBITDA Margin | 28.94% | 27.51% | 21.78% | 20.63% | 20.74% | Upgrade
|
| D&A For EBITDA | 1,975 | 1,970 | 1,812 | 1,489 | 1,311 | Upgrade
|
| EBIT | 7,659 | 5,297 | 3,757 | 2,710 | 2,186 | Upgrade
|
| EBIT Margin | 23.01% | 20.05% | 14.70% | 13.31% | 12.97% | Upgrade
|
| Effective Tax Rate | 31.57% | 29.37% | 28.79% | 31.57% | 32.44% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.